2011
DOI: 10.1210/jc.2011-0620
|View full text |Cite
|
Sign up to set email alerts
|

Serum Selenoprotein P Levels in Patients with Type 2 Diabetes and Prediabetes: Implications for Insulin Resistance, Inflammation, and Atherosclerosis

Abstract: Circulating SeP concentrations were elevated in patients with glucose metabolism dysregulation and were related to various cardiometabolic parameters including insulin resistance, inflammation, and atherosclerosis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
117
5
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 166 publications
(130 citation statements)
references
References 18 publications
7
117
5
1
Order By: Relevance
“…However, our data indicate that treatment with purified SeP directly inhibits angiogenesis in both vascular endothelial cells and mice on euglycemic conditions. Combined with the previous reports showing the elevated production of SeP in type 2 diabetes [15,16], the current data suggest that overproduction of SeP contributes to the onset of impaired angiogenesis in type 2 diabetes.…”
Section: Discussionsupporting
confidence: 85%
See 1 more Smart Citation
“…However, our data indicate that treatment with purified SeP directly inhibits angiogenesis in both vascular endothelial cells and mice on euglycemic conditions. Combined with the previous reports showing the elevated production of SeP in type 2 diabetes [15,16], the current data suggest that overproduction of SeP contributes to the onset of impaired angiogenesis in type 2 diabetes.…”
Section: Discussionsupporting
confidence: 85%
“…We have previously reported that levels of serum SeP and hepatic gene expression of SEPP1 are elevated in type 2 diabetes [15]. More recently, Yang et al have reported that serum levels of SeP are increased in people with impaired glucose tolerance [16]. SeP impairs insulin signal transduction and induced dysregulation of glucose metabolism in skeletal muscle and liver, indicating that SeP functions as a type 2 diabetes-associated hepatokine that causes insulin resistance and hyperglycemia [15].…”
Section: Introductionmentioning
confidence: 99%
“…In a recent study, serum SELP concentrations were higher in patients with type-2 diabetes or prediabetes than those with normal glucose tolerance (275). Moreover, SELP levels correlated with serum C-reactive protein (CRP) levels and carotid intima-media thickness, which are an indicator of inflammation and atherosclerosis, respectively.…”
Section: J Se Supplementation and Inflammation Associated With Diabetesmentioning
confidence: 97%
“…In patients with type 2 diabetes and NAFLD showed Sep serum levels higher than controls [22]. In another study the circulating level of SeP was associated independently with thickness of carotid intimamedia [23].…”
Section: Introductionmentioning
confidence: 90%